Last week, OurCrowd’s founder and CEO Jonathan Medved took part in an inspiring panel discussing Israel’s growth platform for global co-innovation. The event was part of the 18th annual Milken Institute Global Conference:
“Over the past decades, Israel has turned adversity into a competitive advantage. Beyond the geopolitical storms raging around it, Israel’s future rests largely on its ability to continually reinvent its technological mojo and transfer it to partners in other emerging economies. Co-innovation with new partnerships focused on global problems with high growth potential, such as water management, agricultural science for food, alternative energy, health, and of course, cyber-security — in which Israel already has world-beating technology — are key. Israel’s strategic economic plan envisions the scaling up of startup nation models in many regions. Yet this requires closing gaps in economic participation within Israel itself and strengthening ties beyond its “island” economy. At this event, we’ll report on our fieldwork in research, development and training in Israel.”
Global Conference panel – Wed., April 29, 2015
The event was moderated by Glenn Yago, a senior fellow and founder of the Financial Innovations Labs at the Milken Institute and the senior director of the Milken Innovation Center at the Jerusalem Institute. In addition to Jon, the panel speakers included Yossi Beinart, Orna Berry, Yoram Cohen, and Nora Yang.
The Milken Institute is a nonprofit, nonpartisan think tank determined to increase global prosperity by advancing collaborative solutions that widen access to capital, create jobs and improve health. The Institute’s annual Global Conference convenes some of the world’s most extraordinary people to explore solutions to today’s most pressing challenges in financial markets, industry sectors, health, government and education.
Missed it live? View the Global Conference panel recording here or watch the video below.
Beyond Start-Up Nation: Israel’s Growth Platform for Global Co-Innovation
![[Bionaut Labs in Yahoo!finance] Bionaut Labs and Candel Therapeutics announce strategic collaboration in precision-targeted delivery of oncolytic viral immunotherapies](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
